Ocugen Inc (OCGN)
0.9058
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 16:00
0.9058
0.00 (0.00%)
After-Hours: 16:05
Ocugen Shareholders Equity (Quarterly): 40.63M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 40.63M |
| June 30, 2024 | 16.93M |
| March 31, 2024 | 30.26M |
| December 31, 2023 | 40.56M |
| September 30, 2023 | 58.40M |
| June 30, 2023 | 70.28M |
| March 31, 2023 | 75.80M |
| December 31, 2022 | 73.98M |
| September 30, 2022 | 95.30M |
| June 30, 2022 | 114.11M |
| March 31, 2022 | 131.13M |
| December 31, 2021 | 95.82M |
| September 30, 2021 | 107.11M |
| June 30, 2021 | 116.41M |
| March 31, 2021 | 46.49M |
| December 31, 2020 | 21.55M |
| September 30, 2020 | 14.42M |
| June 30, 2020 | 14.62M |
| March 31, 2020 | 7.297M |
| December 31, 2019 | 11.02M |
| September 30, 2019 | -13.09M |
| June 30, 2019 | -8.731M |
| Date | Value |
|---|---|
| March 31, 2019 | -5.532M |
| December 31, 2018 | -0.458M |
| September 30, 2018 | -9.676M |
| June 30, 2018 | -23.44M |
| March 31, 2018 | -20.07M |
| December 31, 2017 | -11.27M |
| September 30, 2017 | -4.813M |
| June 30, 2017 | 0.806M |
| March 31, 2017 | 6.972M |
| December 31, 2016 | 13.57M |
| September 30, 2016 | 4.036M |
| June 30, 2016 | 12.89M |
| March 31, 2016 | 20.59M |
| December 31, 2015 | 28.20M |
| September 30, 2015 | 36.18M |
| June 30, 2015 | 43.86M |
| March 31, 2015 | 51.22M |
| December 31, 2014 | 54.21M |
| September 30, 2014 | 4.028M |
| June 30, 2014 | -90.60M |
| December 31, 2013 | -75.55M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
7.297M
Minimum
Mar 2020
131.13M
Maximum
Mar 2022
59.11M
Average
52.44M
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytokinetics Inc | -13.91M |
| Scholar Rock Holding Corp | 79.20M |
| Mirum Pharmaceuticals Inc | 232.02M |
| SpringWorks Therapeutics Inc | 532.58M |
| NeuroBo Pharmaceuticals Inc | 12.95M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 61.94M |
| Total Liabilities (Quarterly) | 21.31M |
| Debt to Equity Ratio | 0.0711 |
| Current Ratio | 2.580 |
| Net Debt Paydown Yield | -0.01% |